The present invention relates to the use of novel thiazolopyrimidine derivatives of formula I:
wherein all variable substituents are defined as described herein, which are SYK inhibitors and are useful for the treatment of auto-immune and inflammatory diseases.
本发明涉及使用式I所示的新型
噻唑嘧啶衍
生物,其中所有变量取代基的定义如本文所述,这些化合物是SYK
抑制剂,可用于治疗自身免疫和炎症性疾病。